Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctioncalcium ion binding

DCHS2 MYO5A CDHR2 CDH23 CDHR5 CABYR FAT1 FAT2 HMCN2 RPTN PCDH10 FAT4 PCDHGB7 PCDHGB5 PCDHGB3 PCLO PCDHA6 CUBN MACF1 UNC13C PLCH1 PCDHGC3 CDH5 CDH12 CDH17

2.71e-0774920725GO:0005509
GeneOntologyMolecularFunctioncell adhesion molecule binding

CDHR2 OBSCN CDH23 SH3GLB2 CDHR5 ITGA2 ITGA2B PROM1 FASN VWF DOCK9 PPL ICAM5 TLN1 MACF1 SCRIB CDH5 CDH12 CDH17

1.63e-0559920719GO:0050839
GeneOntologyMolecularFunctioncadherin binding

OBSCN CDH23 SH3GLB2 PROM1 FASN DOCK9 PPL TLN1 MACF1 SCRIB CDH5 CDH12 CDH17

5.66e-0533920713GO:0045296
GeneOntologyMolecularFunctiontRNA-4-demethylwyosine synthase activity

TYW1B TYW1

1.07e-0422072GO:0102521
GeneOntologyBiologicalProcesshomophilic cell adhesion via plasma membrane adhesion molecules

DCHS2 CDHR2 CDH23 CDHR5 FAT1 FAT2 HMCN2 PCDH10 FAT4 PCDHGB7 PCDHGB5 PCDHGB3 PCDHA6 PCDHGC3 CDH5 CDH12 CDH17

4.99e-1218720317GO:0007156
GeneOntologyBiologicalProcesscell-cell adhesion via plasma-membrane adhesion molecules

DCHS2 CDHR2 CDH23 CDHR5 FAT1 FAT2 SLITRK2 HMCN2 PCDH10 FAT4 PCDHGB7 PCDHGB5 PCDHGB3 PCDHA6 PCDHGC3 CDH5 CDH12 CDH17

2.19e-0931320318GO:0098742
GeneOntologyBiologicalProcesscell-cell adhesion

CYP1B1 DCHS2 ERBB2 CDHR2 ABCA12 CDH23 CDHR5 ITGA2 ITGA2B ITPKB FAT1 FAT2 SLITRK2 HMCN2 PKHD1 PCDH10 FAT4 PCDHGB7 PCDHGB5 PCDHGB3 AKNA AMBRA1 PCDHA6 ICAM5 TLN1 SCRIB PCDHGC3 CDH5 CDH12 CDH17

2.54e-07107720330GO:0098609
GeneOntologyBiologicalProcessepithelial cell development

RAPGEF6 ARID4B ABCA12 FASN TFCP2L1 FAT1 PKHD1 COL27A1 JMJD1C AKAP9 SCRIB CDH5

1.53e-0526920312GO:0002064
GeneOntologyBiologicalProcessepithelium development

RAPGEF6 ARID4B MYO5A CDHR2 ABCA12 CCNO CDH23 ITGA2 PROM1 FREM2 FASN TFCP2L1 FAT1 PKHD1 USH2A TCTN1 CCDC40 FAT4 FRAS1 IPO7 COL27A1 COMMD5 AIRE AMBRA1 JMJD1C PPL TGFBR3 AKAP9 PHACTR4 SCRIB CDH5

4.58e-05146920331GO:0060429
GeneOntologyBiologicalProcessepithelial cell differentiation

RAPGEF6 ARID4B CDHR2 ABCA12 CCNO CDH23 ITGA2 PROM1 FASN TFCP2L1 FAT1 PKHD1 USH2A FAT4 IPO7 COL27A1 COMMD5 JMJD1C PPL AKAP9 SCRIB CDH5

5.01e-0587020322GO:0030855
GeneOntologyBiologicalProcessintermicrovillar adhesion

CDHR2 CDHR5

9.64e-0522032GO:0090675
GeneOntologyBiologicalProcessepithelial cell morphogenesis

FAT1 PKHD1 COL27A1 JMJD1C SCRIB

1.18e-04492035GO:0003382
GeneOntologyCellularComponentextrinsic component of plasma membrane

CDH23 TOLLIP APOE CUBN PPL AKAP9 SCRIB CDH5 CDH12 CDH17

1.07e-0613720610GO:0019897
GeneOntologyCellularComponentextrinsic component of membrane

CDH23 TOLLIP KALRN APOE CUBN PPL AKAP9 KIAA1755 SCRIB CDH5 CDH12 CDH17

3.18e-0623020612GO:0019898
GeneOntologyCellularComponentcatenin complex

CDH23 CDH5 CDH12 CDH17

2.65e-04322064GO:0016342
GeneOntologyCellularComponentapical part of cell

ERBB2 PLB1 RAPGEF6 CDHR2 CDH23 CDHR5 PROM1 FAT1 PKHD1 USH2A MGAM FAT4 SI CUBN SCRIB OCLN

2.71e-0459220616GO:0045177
GeneOntologyCellularComponentsperm end piece

FSIP2 CABYR

2.88e-0432062GO:0097229
GeneOntologyCellularComponentapical plasma membrane

ERBB2 PLB1 RAPGEF6 CDHR2 CDHR5 PROM1 FAT1 PKHD1 USH2A MGAM SI CUBN SCRIB OCLN

3.55e-0448720614GO:0016324
GeneOntologyCellularComponentcluster of actin-based cell projections

PLB1 CDHR2 CDH23 CDHR5 PROM1 USH2A SI CUBN KPTN

3.83e-042232069GO:0098862
GeneOntologyCellularComponentactin-based cell projection

ERBB2 MYO5A CDHR2 CDH23 CDHR5 PROM1 FAT1 USH2A CUBN KPTN

4.56e-0427820610GO:0098858
GeneOntologyCellularComponentmicrovillus membrane

CDHR2 CDHR5 PROM1 CUBN

5.20e-04382064GO:0031528
GeneOntologyCellularComponentextrinsic component of external side of plasma membrane

APOE CUBN

5.72e-0442062GO:0031232
GeneOntologyCellularComponentEARP complex

VPS52 VPS50

9.48e-0452062GO:1990745
GeneOntologyCellularComponentpostsynapse

ERBB2 MYO5A SH3GLB2 VPS52 SLITRK2 RNF216 PCDH10 KIF17 DAGLA CHRNA6 KALRN PCLO LAMA2 DGKZ KPTN AKAP9 SLC18A2 DROSHA ICAM5 MACF1 SCRIB

1.15e-03101820621GO:0098794
GeneOntologyCellularComponentciliary transition zone

USH2A KIF17 TCTN1 KIAA1549 CEP131

1.24e-03812065GO:0035869
GeneOntologyCellularComponentbasement membrane

FREM1 FREM2 HMCN2 USH2A FRAS1 LAMA2

1.33e-031222066GO:0005604
GeneOntologyCellularComponentpericiliary membrane compartment

USH2A KIF17

1.41e-0362062GO:1990075
GeneOntologyCellularComponentcell leading edge

ERBB2 MYO5A FAT1 USH2A DAGLA APBB2 DGKZ KPTN TLN1 PHACTR4 MACF1 SCRIB OCLN

1.44e-0350020613GO:0031252
GeneOntologyCellularComponentmale germ cell nucleus

MORC1 ACTRT3 BRCA1 AIRE ZFPM2

1.62e-03862065GO:0001673
MousePhenocryptophthalmos

FREM1 FREM2 FRAS1

1.90e-0631743MP:0005242
MousePhenoabsent eyelids

FREM1 FREM2 FRAS1 SCRIB

1.06e-05121744MP:0001341
DomainCadherin

DCHS2 CDHR2 CDH23 CDHR5 FREM1 FREM2 FAT1 FAT2 PCDH10 FAT4 PCDHGB7 PCDHGB5 PCDHGB3 PCDHA6 PCDHGC3 CDH5 CDH12 CDH17

7.54e-1611820518IPR002126
DomainCA

DCHS2 CDHR2 CDH23 CDHR5 FREM2 FAT1 FAT2 PCDH10 FAT4 PCDHGB7 PCDHGB5 PCDHGB3 PCDHA6 PCDHGC3 CDH5 CDH12 CDH17

8.47e-1511520517SM00112
DomainCadherin_CS

DCHS2 CDHR2 CDH23 CDHR5 FAT1 FAT2 PCDH10 FAT4 PCDHGB7 PCDHGB5 PCDHGB3 PCDHA6 PCDHGC3 CDH5 CDH12 CDH17

5.99e-1410920516IPR020894
DomainCADHERIN_1

DCHS2 CDHR2 CDH23 CDHR5 FAT1 FAT2 PCDH10 FAT4 PCDHGB7 PCDHGB5 PCDHGB3 PCDHA6 PCDHGC3 CDH5 CDH12 CDH17

1.07e-1311320516PS00232
DomainCADHERIN_2

DCHS2 CDHR2 CDH23 CDHR5 FAT1 FAT2 PCDH10 FAT4 PCDHGB7 PCDHGB5 PCDHGB3 PCDHA6 PCDHGC3 CDH5 CDH12 CDH17

1.23e-1311420516PS50268
Domain-

DCHS2 CDHR2 CDH23 CDHR5 FAT1 FAT2 PCDH10 FAT4 PCDHGB7 PCDHGB5 PCDHGB3 PCDHA6 PCDHGC3 CDH5 CDH12 CDH17

1.23e-13114205162.60.40.60
DomainCadherin-like

DCHS2 CDHR2 CDH23 CDHR5 FAT1 FAT2 PCDH10 FAT4 PCDHGB7 PCDHGB5 PCDHGB3 PCDHA6 PCDHGC3 CDH5 CDH12 CDH17

1.63e-1311620516IPR015919
DomainCadherin

DCHS2 CDHR2 CDH23 FAT1 FAT2 PCDH10 FAT4 PCDHGB7 PCDHGB5 PCDHGB3 PCDHA6 PCDHGC3 CDH5 CDH12 CDH17

1.70e-1211320515PF00028
DomainLAM_G_DOMAIN

FAT1 FAT2 USH2A FAT4 COL27A1 LAMA2

3.35e-06382056PS50025
DomainLaminin_G

FAT1 FAT2 USH2A FAT4 COL27A1 LAMA2

4.09e-05582056IPR001791
DomainCadherin_tail

PCDHGB7 PCDHGB5 PCDHGB3 PCDHA6 PCDHGC3

4.97e-05372055PF15974
DomainCadherin_CBD

PCDHGB7 PCDHGB5 PCDHGB3 PCDHA6 PCDHGC3

4.97e-05372055IPR031904
DomainLaminin_G_2

FAT1 FAT2 USH2A FAT4 LAMA2

7.30e-05402055PF02210
DomainCadherin_2

PCDH10 PCDHGB7 PCDHGB5 PCDHGB3 PCDHA6 PCDHGC3

7.83e-05652056PF08266
DomainCadherin_N

PCDH10 PCDHGB7 PCDHGB5 PCDHGB3 PCDHA6 PCDHGC3

7.83e-05652056IPR013164
DomainCadherin_C

PCDH10 PCDHGB7 PCDHGB5 PCDHGB3 PCDHGC3

9.28e-05422055IPR032455
DomainCadherin_C_2

PCDH10 PCDHGB7 PCDHGB5 PCDHGB3 PCDHGC3

9.28e-05422055PF16492
DomainCalx_beta

FREM1 FREM2 FRAS1

1.04e-0492053IPR003644
DomainCalx-beta

FREM1 FREM2 FRAS1

1.04e-0492053PF03160
DomainLamG

FAT1 FAT2 USH2A FAT4 LAMA2

1.16e-04442055SM00282
DomainSec16_CCD

SEC16A SEC16B

1.20e-0422052IPR024340
DomainSec16

SEC16A SEC16B

1.20e-0422052IPR024880
DomainSec16

SEC16A SEC16B

1.20e-0422052PF12932
DomaintRNA_wybutosine-synth

TYW1B TYW1

1.20e-0422052IPR013917
DomainWyosine_form

TYW1B TYW1

1.20e-0422052PF08608
DomainSpectrin_repeat

KALRN CCDC141 PPL MACF1

2.70e-04292054IPR002017
DomainSec16_C

SEC16A SEC16B

3.57e-0432052PF12931
DomainACE1_Sec16_Sec31

SEC16A SEC16B

3.57e-0432052IPR024298
Domain-

FAT1 FAT2 USH2A FAT4 LAMA2 WDFY3

6.28e-049520562.60.120.200
DomainGlyco_hydro_31_CS

MGAM SI

7.09e-0442052IPR030459
DomainGal_mutarotase_N

MGAM SI

7.09e-0442052IPR031727
DomainNtCtMGAM_N

MGAM SI

7.09e-0442052PF16863
DomainBiotin_BS

ACACB PC

1.17e-0352052IPR001882
DomainGLYCOSYL_HYDROL_F31_2

MGAM SI

1.17e-0352052PS00707
DomainBiotin_COase_C

ACACB PC

1.17e-0352052IPR005482
DomainBC

ACACB PC

1.17e-0352052PS50979
DomainBiotin_carb_C

ACACB PC

1.17e-0352052SM00878
DomainBiotin_carb_C

ACACB PC

1.17e-0352052PF02785
DomainBiotin_carboxylation_dom

ACACB PC

1.17e-0352052IPR011764
DomainBIOTIN

ACACB PC

1.17e-0352052PS00188
DomainGlyco_hydro_31_AS

MGAM SI

1.75e-0362052IPR030458
DomainGAR

GAS2L1 MACF1

1.75e-0362052PS51460
DomainCP2

TFCP2L1 TFCP2

1.75e-0362052PF04516
DomainCP2

TFCP2L1 TFCP2

1.75e-0362052IPR007604
DomainRudment_hybrid_motif

ACACB PC

1.75e-0362052IPR011054
DomainRIIa

CABYR PRKAR2A

1.75e-0362052SM00394
DomainGAS2

GAS2L1 MACF1

1.75e-0362052PF02187
Domain-

GAS2L1 MACF1

1.75e-03620523.30.920.20
DomainGAS_dom

GAS2L1 MACF1

1.75e-0362052IPR003108
DomainGAS2

GAS2L1 MACF1

1.75e-0362052SM00243
Pubmed

Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.

MON2 MTA2 CAAP1 ERBB2 ARID4B ACTR5 ABCA12 TSPYL2 ZNF518A FAT1 VPS52 HMCN2 BRCA1 SEC16A ANKRD52 RAE1 ARHGAP23 VPS50 KIAA1549 AMBRA1 CHD9 TTC7A DROSHA TBK1 MACF1 WDFY3 MRGBP SCRIB KIF18B

3.41e-1111162082931753913
Pubmed

A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.

ZBTB38 OBSCN SH3GLB2 BIRC6 MYO18B RABGGTB VWF IPO7 KALRN DOCK9 LAMA2 CCDC141 JMJD1C AKAP9 DROSHA TBK1 TLN1 MACF1

1.46e-094972081823414517
Pubmed

Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.

ACACB BIRC6 TASOR2 PTPN3 FAT1 VPS52 BRCA1 SEC16A PCDH10 GOLGB1 IGSF3 SMAP1 FAT4 APBB2 HUWE1 PPL SEC24C PHACTR4 CEP131 SCRIB OCLN PC

2.02e-097772082235844135
Pubmed

A central chaperone-like role for 14-3-3 proteins in human cells.

ERBB2 RAPGEF6 HDAC4 MATK ITPKB FSIP2 PTPN3 WWC2 SEC16A GOLGB1 EHBP1 ARHGEF5 LARP1B AKAP9 DCP1B PHACTR4 MACF1 CEP131 SCRIB PLCH1 PC SAMD4A AHNAK2

2.56e-098612082336931259
Pubmed

Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.

BIRC6 ZNF518A SEC16A DAGLA PRUNE2 DOCK9 TTC7A TLN1 HELZ2 MACF1 WDFY3 SCRIB

1.30e-082252081212168954
Pubmed

Expression of mouse dchs1, fjx1, and fat-j suggests conservation of the planar cell polarity pathway identified in Drosophila.

DCHS2 FAT1 FAT2 FAT4

4.29e-087208416059920
Pubmed

A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.

ERBB2 RAPGEF6 ACACB ITGA2 SEC16A GOLGB1 EHBP1 APBB2 PHACTR4 LRRC1 MACF1 SCRIB OCLN PLCH1 SLC12A7

4.42e-084212081536976175
Pubmed

A dual-activity topoisomerase complex regulates mRNA translation and turnover.

MON2 MTA2 ERBB2 RAPGEF6 OBSCN BIRC6 FASN FAT1 SEC16A IGSF3 FRAS1 KALRN DOCK9 AKNA AMBRA1 HUWE1 GAS2L1 TLN1 HELZ2 NPRL3 CEP131 WDFY3 PC AHNAK2

5.88e-0811052082435748872
Pubmed

Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.

RAPGEF6 NCAPG2 XAB2 FREM2 RNF216 FRAS1 ARHGAP23 ARHGEF5 AMBRA1 JMJD1C DROSHA TBK1 MARF1 SCRIB PLCH1 SLC12A7 PCDHGC3 RAVER1

8.86e-086502081838777146
Pubmed

KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.

MTA2 MYO5A ITGA2 ITPKB FASN HECW2 SEC16A TOLLIP DNAH6 DAGLA SMAP1 VWF ARHGAP23 KALRN PCLO KIAA1549 DGKZ APOE GAS2L1 SEC24C ICAM5 TLN1 PRKAR2A MACF1 SCRIB PLCH1 PC

1.43e-0714312082737142655
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

MON2 MAP3K4 SEC16A PCDH10 KIF17 FRAS1 DOCK9 VPS8 AKAP9 SEC24C TLN1 GPCPD1 MACF1 SCRIB

1.93e-074072081412693553
Pubmed

A striking organization of a large family of human neural cadherin-like cell adhesion genes.

FAT2 PCDH10 PCDHGB7 PCDHGB5 PCDHGB3 PCDHA6 PCDHGC3

2.62e-0772208710380929
Pubmed

Cadherin superfamily genes: functions, genomic organization, and neurologic diversity.

CDHR5 PCDH10 PCDHGB7 PCDHGB5 PCDHGB3 PCDHA6 PCDHGC3

3.17e-0774208710817752
Pubmed

Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members.

FAT2 PCDH10 PCDHGB7 PCDHGB5 PCDHGB3 PCDHA6 PCDHGC3

4.17e-0777208710835267
Pubmed

Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes.

FAT2 PCDH10 PCDHGB7 PCDHGB5 PCDHGB3 PCDHA6 PCDHGC3

5.43e-0780208710716726
Pubmed

E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.

OBSCN ZNF226 BIRC6 FREM2 SAMD9L HECW2 PKHD1 PCDH10 FAT4 PCDHGB3 PCLO HUWE1 ADO DROSHA TBK1 TLN1 SCRIB RBM41

5.44e-077362081829676528
Pubmed

The role of FREM2 and FRAS1 in the development of congenital diaphragmatic hernia.

FREM1 FREM2 FRAS1

8.40e-074208329618029
Pubmed

Deficiency of FRAS1-related extracellular matrix 1 (FREM1) causes congenital diaphragmatic hernia in humans and mice.

FREM1 FREM2 FRAS1

8.40e-074208323221805
Pubmed

Frem1 activity is regulated by Sonic hedgehog signaling in the cranial neural crest mesenchyme during midfacial morphogenesis.

FREM1 FREM2 FRAS1

8.40e-074208336495293
Pubmed

Differential localization profile of Fras1/Frem proteins in epithelial basement membranes of newborn and adult mice.

FREM1 FREM2 FRAS1

8.40e-074208318563433
Pubmed

Large-scale proteomics and phosphoproteomics of urinary exosomes.

CDHR2 CDHR5 PROM1 FASN FAT1 PKHD1 PGLS TOLLIP MNDA NAA16 VWF KALRN VPS50 HUWE1 APOE CUBN PPL TGFBR3 TLN1 SERPINB1 PRKAR2A

9.23e-0710162082119056867
Pubmed

Large-scale characterization of HeLa cell nuclear phosphoproteins.

CAAP1 RAPGEF6 ARID4B MATK WWC2 PPIG FASN SEC16A SEC16B HUWE1 TFAP4 PPL SEC24C PHACTR4 HELZ2 SCRIB CDH17 RAVER1

1.12e-067742081815302935
Pubmed

Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.

RAPGEF6 ACACB BIRC6 FASN SEC16A ANKRD52 GOLGB1 EHBP1 HUWE1 JMJD1C TBK1 CEP131 PC

1.64e-064182081334709266
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

BIRC6 FAT2 SAMD9L PRUNE2 EHBP1 SEC16B ARHGAP23 COL27A1 ATP10A JMJD1C HELZ2 MACF1 PLCH1 NEURL4

1.88e-064932081415368895
Pubmed

The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.

CDHR5 ITGA2 PROM1 PTPN3 FAT1 SLITRK2 NRK IGSF3 EHBP1 DOCK9 KIAA1549 PHACTR4 SCRIB OCLN SLC12A7

2.00e-065692081530639242
Pubmed

Primary Ciliary Dyskinesia Associated Disease-Causing Variants in CCDC39 and CCDC40 Cause Axonemal Absence of Inner Dynein Arm Heavy Chains DNAH1, DNAH6, and DNAH7.

DNAH6 CCDC40 DNAH1

2.09e-065208339056782
Pubmed

Talin is required for integrin-mediated platelet function in hemostasis and thrombosis.

ITGA2 ITGA2B TLN1

2.09e-065208318086863
Pubmed

Novel frem1-related mouse phenotypes and evidence of genetic interactions with gata4 and slit3.

FREM1 FREM2 FRAS1

2.09e-065208323536828
Pubmed

Basement membrane localization of Frem3 is independent of the Fras1/Frem1/Frem2 protein complex within the sublamina densa.

FREM1 FREM2 FRAS1

2.09e-065208317596926
Pubmed

Spatiotemporal distribution of Fras1/Frem proteins during mouse embryonic development.

FREM1 FREM2 FRAS1

2.09e-065208317251066
Pubmed

SR protein kinases promote splicing of nonconsensus introns.

CDH23 PPIG FAT1 SAMD9L HMCN2 MYO18B DNAH6 SEC16B SMCHD1 ATP10A JMJD1C MACF1

2.09e-063612081226167880
Pubmed

Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.

RAPGEF6 HDAC4 ACACB SH3GLB2 BIRC6 SEC16A ANKRD52 RAE1 KIAA1549 AKAP9 TBK1 CEP131 SAMD4A

3.32e-064462081324255178
Pubmed

Comparative DNA sequence analysis of mouse and human protocadherin gene clusters.

PCDH10 PCDHGB7 PCDHGB5 PCDHGB3 PCDHA6 PCDHGC3

3.42e-0668208611230163
Pubmed

Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.

ERBB2 HDAC4 MYO5A TSPYL2 OBSCN TASOR2 ITPKB DAGLA GOLGB1 PRUNE2 EHBP1 APBB2 CHD9 MSH5 HUWE1 NAALADL2 ATP10A JMJD1C TFAP4 DNAH1 TBK1 LRRC1 MACF1 NRG3 RAVER1

3.49e-0614892082528611215
Pubmed

A direct functional link between the multi-PDZ domain protein GRIP1 and the Fraser syndrome protein Fras1.

FREM1 FREM2 FRAS1 LAMA2

3.56e-0618208414730302
Pubmed

Cullin 1 (CUL1) Promotes Primary Ciliogenesis through the Induction of Ubiquitin-Proteasome-Dependent Dvl2 Degradation.

CDH23 FREM1 FAT2 FRAS1 COL27A1 AKAP9 MACF1 PC

4.01e-06152208834299191
Pubmed

Mild recessive mutations in six Fraser syndrome-related genes cause isolated congenital anomalies of the kidney and urinary tract.

FREM1 FREM2 FRAS1

4.16e-066208324700879
Pubmed

Frem3, a member of the 12 CSPG repeats-containing extracellular matrix protein family, is a basement membrane protein with tissue distribution patterns distinct from those of Fras1, Frem2, and QBRICK/Frem1.

FREM1 FREM2 FRAS1

4.16e-066208317462874
Pubmed

Identification of Erbin interlinking MuSK and ErbB2 and its impact on acetylcholine receptor aggregation at the neuromuscular junction.

ERBB2 LRRC1 SCRIB

4.16e-066208320463225
Pubmed

Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.

MON2 SAAL1 MYO5A BIRC6 PHKA1 PTPN3 WWC2 SEC16A ANKRD52 IPO7 KIAA1549 HUWE1 AKAP9 LRRC1 CEP131 SCRIB PC SLC12A7 NEURL4 RAVER1

5.68e-0610492082027880917
Pubmed

TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.

ARID4B ACACB ORC6 NAP1L3 ITPKB ANKRD52 IGSF3 FAT4 IPO7 PRELP SERPINB1 WDFY3 CDH17 AHNAK2 RAVER1

7.91e-066382081531182584
Pubmed

Defining the membrane proteome of NK cells.

CALCOCO2 MTA2 MYO5A ORC6 BIRC6 NCAPG2 XAB2 FASN GOLGB1 IPO7 DOCK9 VPS50 AKNA HUWE1 APOE DCP1B HELZ2 MARF1 SERPINB1 PRKAR2A ITPRIP

8.01e-0611682082119946888
Pubmed

The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices.

FREM1 FREM2 HMCN2 FRAS1 VWF COL27A1 LAMA2 PRELP

8.03e-06167208822159717
Pubmed

E-cadherin interactome complexity and robustness resolved by quantitative proteomics.

ERBB2 SH3GLB2 FASN GOLGB1 EHBP1 ARHGAP23 DOCK9 PPL TTC7A TLN1 PHACTR4 MACF1 SCRIB OCLN

8.90e-065652081425468996
Pubmed

HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.

MTA2 CAAP1 XAB2 PPIG FASN GCLM SEC16A SEC16B IPO7 RAE1 SMCHD1 LARP1B TFCP2 AKAP9 SEC24C DROSHA TBK1 TLN1 HELZ2 MARF1 CEP131 MRGBP PC

8.93e-0613712082336244648
Pubmed

Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.

MTA2 MYO5A BIRC6 XAB2 TASOR2 FASN SEC16A ANKRD52 IPO7 SMCHD1 HUWE1 SEC24C TLN1 HELZ2 MACF1

1.04e-056532081522586326
Pubmed

Importance of Endogenous Atrial and Brain Natriuretic Peptides in Murine Embryonic Vascular and Organ Development.

NPR1 VWF CDH5

1.15e-058208326517044
Pubmed

Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.

RAPGEF6 HDAC4 ACACB TSPYL2 TASOR2 PRR14 PRUNE2 IPO7 ARHGEF5 CCDC141 TLN1 NEURL4

1.23e-054302081235044719
Pubmed

Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.

MON2 SH3GLB2 RMI1 SEC16A ANKRD52 GOLGB1 RAE1 VPS50 HUWE1 ADO DROSHA TBK1 MACF1 CEP131

1.39e-055882081438580884
Pubmed

The extracellular matrix gene Frem1 is essential for the normal adhesion of the embryonic epidermis.

FREM1 FREM2 FRAS1

2.45e-0510208315345741
Pubmed

The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch.

RAPGEF6 FASN SEC16A GOLGB1 IPO7 JMJD1C TLN1 SCRIB AHNAK2

2.60e-05256208933397691
Pubmed

Basement membrane assembly of the integrin α8β1 ligand nephronectin requires Fraser syndrome-associated proteins.

FREM1 FREM2 FRAS1 LAMA2

2.63e-0529208422613833
Pubmed

BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.

ERBB2 FASN GCLM SEC16A GOLGB1 EHBP1 IPO7 JMJD1C SEC24C TLN1 PHACTR4 MACF1 SCRIB OCLN PLCH1

2.66e-057082081539231216
Pubmed

SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.

MTA2 RAPGEF6 FASN SEC16A SMCHD1 HUWE1 APOE JMJD1C ICAM5 TLN1 PHACTR4 SCRIB PC

2.99e-055492081338280479
Pubmed

Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.

ZMYND19 SAAL1 RAPGEF6 OBSCN WWC2 KCNJ8 SEC16A TOLLIP GOLGB1 DOCK9 DGKZ MSH5 HUWE1 CUBN SEC24C TYW1B ITPRIP MACF1 TYW1

3.12e-0510842081911544199
Pubmed

RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.

SEC16A GOLGB1 EHBP1 KIAA1549 JMJD1C MACF1 SCRIB OCLN AHNAK2

3.22e-05263208934702444
Pubmed

Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.

DCHS2 ZBTB38 MYO5A TSPYL2 NAP1L3 SH3GLB2 XAB2 TOLLIP RNF216 VWF KALRN APBB2 AIRE CHD9 HUWE1 APOE DROSHA MACF1 WDFY3 SCRIB PC

3.28e-0512852082135914814
Pubmed

Atypical Cadherin Fat1 Is Required for Lens Epithelial Cell Polarity and Proliferation but Not for Fiber Differentiation.

FAT1 FAT4 SCRIB

3.36e-0511208326114487
Pubmed

VANGL2 inhibits antiviral IFN-I signaling by targeting TBK1 for autophagic degradation.

CALCOCO2 TOLLIP TBK1

3.36e-0511208337352355
Pubmed

Csk homologous kinase (CHK) and ErbB-2 interactions are directly coupled with CHK negative growth regulatory function in breast cancer.

ERBB2 MATK

3.56e-052208212122014
Pubmed

655Val and 1170Pro ERBB2 SNPs in familial breast cancer risk and BRCA1 alterations.

ERBB2 BRCA1

3.56e-052208217452776
Pubmed

HUWE1 interacts with BRCA1 and promotes its degradation in the ubiquitin-proteasome pathway.

BRCA1 HUWE1

3.56e-052208224342616
Pubmed

Dual fatty acid synthase and HER2 signaling blockade shows marked antitumor activity against breast cancer models resistant to anti-HER2 drugs.

ERBB2 FASN

3.56e-052208226107737
Pubmed

Increased atherosclerosis and smooth muscle cell hypertrophy in natriuretic peptide receptor A-/-apolipoprotein E-/- mice.

NPR1 APOE

3.56e-052208212702516
Pubmed

Clinical and therapeutic relevance of the metabolic oncogene fatty acid synthase in HER2+ breast cancer.

ERBB2 FASN

3.56e-052208227714708
Pubmed

HUWE1 interacts with BRCA1 and promotes its degradation in the ubiquitin-proteasome pathway.

BRCA1 HUWE1

3.56e-052208224472556
Pubmed

Modulation of CP2 family transcriptional activity by CRTR-1 and sumoylation.

TFCP2L1 TFCP2

3.56e-052208220661472
Pubmed

Platelet collagen receptor alpha2beta1 integrin and glycoprotein IIIa Pl(A1/A2) polymorphisms are not associated with nephropathy in type 2 diabetes.

ITGA2 ITGA2B

3.56e-052208211728949
Pubmed

Cytochrome P450 1B1 Contributes to the Development of Angiotensin II-Induced Aortic Aneurysm in Male Apoe(-/-) Mice.

CYP1B1 APOE

3.56e-052208227301358
Pubmed

Exome sequencing and network analysis identifies shared mechanisms underlying spinocerebellar ataxia.

TGM6 FAT2

3.56e-052208229053796
Pubmed

Overlapping and divergent localization of Frem1 and Fras1 and its functional implications during mouse embryonic development.

FREM1 FRAS1

3.56e-052208217240369
Pubmed

Discovery of a gene family critical to wyosine base formation in a subset of phenylalanine-specific transfer RNAs.

TYW1B TYW1

3.56e-052208216162496
Pubmed

Modifying murine von Willebrand factor A1 domain for in vivo assessment of human platelet therapies.

ITGA2B VWF

3.56e-052208218084279
Pubmed

A homozygous mutation p.Arg2167Trp in FREM2 causes isolated cryptophthalmos.

FREM1 FREM2

3.56e-052208229688405
Pubmed

Gain and loss of function for glutathione synthesis: impact on advanced atherosclerosis in apolipoprotein E-deficient mice.

GCLM APOE

3.56e-052208221868708
Pubmed

A myosin family tree.

MYO5A CDH23

3.56e-052208210984423
Pubmed

Contribution of the Individual Small Intestinal α-Glucosidases to Digestion of Unusual α-Linked Glycemic Disaccharides.

MGAM SI

3.56e-052208227480812
Pubmed

Toll-interacting protein deficiency promotes neurodegeneration via impeding autophagy completion in high-fat diet-fed ApoE-/- mouse model.

TOLLIP APOE

3.56e-052208227720815
Pubmed

Tollip Deficiency Alters Atherosclerosis and Steatosis by Disrupting Lipophagy.

TOLLIP APOE

3.56e-052208228396568
Pubmed

FASN, ErbB2-mediated glycolysis is required for breast cancer cell migration.

ERBB2 FASN

3.56e-052208226936618
Pubmed

Expressions of fatty acid synthase and HER2 are correlated with poor prognosis of ovarian cancer.

ERBB2 FASN

3.56e-052208225433947
Pubmed

Myeloid-Specific Deletion of Diacylglycerol Lipase α Inhibits Atherogenesis in ApoE-Deficient Mice.

DAGLA APOE

3.56e-052208226731274
Pubmed

LRRC1 knockdown downregulates MACF1 to inhibit the malignant progression of acute myeloid leukemia by inactivating β-catenin/c-Myc signaling.

LRRC1 MACF1

3.56e-052208238165568
Pubmed

Identification of two novel CAKUT-causing genes by massively parallel exon resequencing of candidate genes in patients with unilateral renal agenesis.

FREM2 FRAS1

3.56e-052208221900877
Pubmed

Heterophilic and homophilic cadherin interactions in intestinal intermicrovillar links are species dependent.

CDHR2 CDHR5

3.56e-052208234871294
Pubmed

The Tumor Suppressor SCRIB is a Negative Modulator of the Wnt/β-Catenin Signaling Pathway.

LRRC1 SCRIB

3.56e-052208231513346
Pubmed

Interaction between fatty acid synthase and human epidermal growth receptor 2 (HER2) in osteosarcoma cells.

ERBB2 FASN

3.56e-052208225674245
Pubmed

[Expressions of integrinalpha2beta1 and CD133 in benign prostatic hyperplasia complicated by prostatitis and their significance].

ITGA2 PROM1

3.56e-052208222049795
Pubmed

Highly accurate two-gene classifier for differentiating gastrointestinal stromal tumors and leiomyosarcomas.

OBSCN PRUNE2

3.56e-052208217360660
Pubmed

Molecular study of 33 families with Fraser syndrome new data and mutation review.

FREM2 FRAS1

3.56e-052208218671281
Pubmed

Platelet adhesion via glycoprotein IIb integrin is critical for atheroprogression and focal cerebral ischemia: an in vivo study in mice lacking glycoprotein IIb.

ITGA2B APOE

3.56e-052208216103235
Pubmed

Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells.

ERBB2 FASN

3.56e-052208215235125
Pubmed

Novel loss of function variants in FRAS1 AND FREM2 underlie renal agenesis in consanguineous families.

FREM2 FRAS1

3.56e-052208232643034
Pubmed

Differential expression of fatty acid synthase (FAS) and ErbB2 in nonmalignant and malignant oral keratinocytes.

ERBB2 FASN

3.56e-052208218528705
Pubmed

Usherin is required for maintenance of retinal photoreceptors and normal development of cochlear hair cells.

CDH23 USH2A

3.56e-052208217360538
Pubmed

A HUWE1 defect causes PARP inhibitor resistance by modulating the BRCA1-∆11q splice variant.

BRCA1 HUWE1

3.56e-052208237491606
Pubmed

Interaction between the α-glucosidases, sucrase-isomaltase and maltase-glucoamylase, in human intestinal brush border membranes and its potential impact on disaccharide digestion.

MGAM SI

3.56e-052208236968271
Pubmed

Selective inactivation of the Arg-Gly-Asp-Ser (RGDS) binding site in von Willebrand factor by site-directed mutagenesis.

ITGA2B VWF

3.56e-05220821737795
Pubmed

Silencing of a targeted protein in in vivo platelets using a lentiviral vector delivering short hairpin RNA sequence.

ITGA2B TLN1

3.56e-052208217872456
Pubmed

Expression status of fatty acid synthase (FAS) but not HER2 is correlated with the differentiation grade and prognosis of esophageal carcinoma.

ERBB2 FASN

3.56e-052208223419663
InteractionPFN1 interactions

MON2 CALCOCO2 RAPGEF6 MYO5A BIRC6 PHKA1 PPIG FASN BRCA1 SEC16A TOLLIP GOLGB1 PCLO AKAP9 DCP1B PRKAR2A MACF1 CEP131 AHNAK2

1.29e-0650920619int:PFN1
InteractionXAGE1A interactions

TSPYL2 FREM2 FAT1 FAT4 FRAS1 PCDHGC3

3.54e-06412066int:XAGE1A
InteractionCEACAM8 interactions

GLB1L FREM2 FAT1 IGSF3 FAT4 FRAS1 KIAA1549 APOE TYW1

3.75e-061192069int:CEACAM8
InteractionGOLGA1 interactions

MON2 RAPGEF6 BIRC6 VPS52 SEC16A ANKRD52 GOLGB1 MACF1 CEP131 AHNAK2

1.95e-0518320610int:GOLGA1
GeneFamilyCadherin related

DCHS2 CDHR2 CDH23 CDHR5 FAT1 FAT2 FAT4

1.82e-1117133724
GeneFamilyClustered protocadherins

PCDHGB7 PCDHGB5 PCDHGB3 PCDHA6 PCDHGC3

1.08e-0464133520
GeneFamilyPDZ domain containing

RAPGEF6 PTPN3 ARHGAP23 PCLO SCRIB AHNAK2

9.13e-0415213361220
GeneFamilyEF-hand domain containing|Plakins

PPL MACF1

1.46e-0381332939
GeneFamilyArmadillo repeat containing|Protein phosphatase 1 regulatory subunits

ITGA2B BRCA1 AKAP9 PHACTR4 MARF1 OCLN

2.23e-031811336694
GeneFamilyPleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing

HECW2 TOLLIP PCLO

2.33e-03361333823
CoexpressionSENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN

ACACB ABCA12 PROM1 FREM2 TFCP2L1 PXDNL COL27A1 TGFBR3 AHNAK2

1.16e-051752089M6750
CoexpressionLAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2

ZBTB38 PKHD1 GOLGB1 PRUNE2 EHBP1 FRAS1 PCLO CHD9 CUBN WDFY3

1.16e-0522120810M39222
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ABCA12 OBSCN FREM1 FREM2 FAT1 SLITRK2 NRK PKHD1 USH2A PCDH10 MGAM FAT4 FRAS1 KALRN PCLO DNAH1 UNC13C PLCH1

8.70e-19184208182cbed6462fea2622871bb7e49b0df3d984239281
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ABCA12 OBSCN FREM1 FREM2 FAT1 SLITRK2 NRK PKHD1 USH2A PCDH10 MGAM FAT4 FRAS1 KALRN PCLO DNAH1 UNC13C PLCH1

8.70e-19184208182b19a8c5f823e00812908b23e66bb4e563278aff
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ABCA12 OBSCN FREM1 FREM2 FAT1 SLITRK2 NRK PKHD1 USH2A PCDH10 MGAM FAT4 FRAS1 KALRN PCLO DNAH1 UNC13C PLCH1

8.70e-1918420818ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCellfacs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ABCA12 NALCN PKHD1 USH2A DNAH6 FRAS1 PCLO APOE CUBN DNAH1 UNC13C PLCH1

2.79e-111692081212bdc709bc000d7f9061ecd9fbd57233eaacb7e2
ToppCellwk_15-18-Epithelial-Distal_epithelial_progenitor-epi-tip_intermediate|wk_15-18 / Celltypes from embryonic and fetal-stage human lung

ERBB2 FREM2 TFCP2L1 PKHD1 PCDH10 TRABD2A FRAS1 COL27A1 KIAA1549 TBK1 UNC13C

1.26e-0918520811636505a3d96f75d951ab42bcf8af6ae07abc732d
ToppCell10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue

MON2 ARID4B TSPYL2 BIRC6 TASOR2 GOLGB1 SMCHD1 HUWE1 JMJD1C GPCPD1 MACF1

1.49e-0918820811ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCellChildren_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

DCHS2 OBSCN SLITRK2 HECW2 KALRN DOCK9 ZFPM2 TGFBR3 NRG3 CDH5

2.31e-08190208100a351609a72fd638c84b2435782e312ee6a33aac
ToppCell10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue

MON2 RAPGEF6 ARID4B HDAC4 TSPYL2 SMCHD1 DOCK9 JMJD1C GPCPD1 MACF1

2.56e-081922081047646d7e4990be85072987f92bf18d52f8da752e
ToppCellFibroblasts-DKK3+_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues

FAT1 HMCN2 PXDNL NRK IGSF3 PRUNE2 LAMA2 ATP10A PRELP AHNAK2

3.11e-081962081024d64b67aa9b0e8215ad06f9101c1314b3483620
ToppCellwk_15-18-Mesenchymal-Chondrocyte-ASPN+_chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung

ACACB PROM1 NRK MROH7 COL27A1 DNAH1 PRELP WDFY3 AHNAK2

1.66e-071782089a55130670aa95a87b833dd3cd2de461d779e4c06
ToppCellCOVID-19-kidney-PCT-S1|COVID-19 / Disease (COVID-19 only), tissue and cell type

CYP24A1 PROM1 FAT1 PKHD1 PRUNE2 FRAS1 COL27A1 KIAA1549 CUBN

2.10e-0718320896878d14026c3df6aa12e45dfad94b32fa9d9b0b7
ToppCellAnterior_Cingulate_gyrus_(CgG)-Non-neuronal-Endothelial_Myeloid-Endo|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

TNFRSF10D PROM1 SAMD9L VWF ARHGEF5 ATP10A HELZ2 OCLN CDH5

2.10e-071832089c7fc96ac1d5d31ccefe0c1fc6ec76c7d8607a172
ToppCellAnterior_Cingulate_gyrus_(CgG)-Non-neuronal-Endothelial_Myeloid-Endo-Endothelial|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

TNFRSF10D PROM1 SAMD9L VWF ARHGEF5 ATP10A HELZ2 OCLN CDH5

2.10e-0718320896cdadb3ece45a94a2915063aa461048e1d371ccd
ToppCellAnterior_Cingulate_gyrus_(CgG)-Non-neuronal-Endothelial_Myeloid-Endo-Endothelial-Endo_L2-5_CLDN5|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

TNFRSF10D PROM1 SAMD9L VWF ARHGEF5 ATP10A HELZ2 OCLN CDH5

2.10e-0718320898714d3e7663c93cdf9b25b647353572e136f30c3
ToppCellTCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-4|TCGA-Thryoid / Sample_Type by Project: Shred V9

CYP1B1 DCHS2 DAGLA IGSF3 EHBP1 IPO7 DOCK9 PPL AHNAK2

2.20e-071842089d9659d1e4465fec68f48a22edef443f354f6c7cf
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

ZBTB38 CDHR2 CDHR5 PKHD1 PRUNE2 CUBN KIAA1755 PLPP4 PC

2.42e-071862089b1edc341d6684b347dc9e21b34f62f51d095d735
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PROM1 FAT1 PKHD1 PRUNE2 COL27A1 CUBN NRG3 PLCH1 SAMD4A

2.42e-071862089f28d72b47624b69a580b4429e2be560a26898591
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

ITGA2 FREM1 ITPKB TFCP2L1 NRK PKHD1 FRAS1 APBB2 NAALADL2

2.77e-071892089975c0f079903ae36b0ffa54e86294d42ec7697de
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

PROM1 PTPN3 TFCP2L1 PKHD1 FRAS1 PPL NRG3 OCLN SAMD4A

2.77e-071892089aadb7a2de4cbe7f0958651f2739bba430b93f5c1
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

ITGA2 FREM1 ITPKB TFCP2L1 NRK PKHD1 FRAS1 APBB2 NAALADL2

2.77e-0718920897eb8f5a951e80f1cfac4d7c9eb169f4eb100c917
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

PROM1 PTPN3 TFCP2L1 PKHD1 FRAS1 PPL NRG3 OCLN SAMD4A

2.77e-0718920898977f3295b7df7c7474b3f371de90a82ae4bb50c
ToppCellCOVID-19-lung-Vein_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type

HECW2 FAT4 VWF KALRN DOCK9 TGFBR3 LRRC1 ITPRIP NRG3

2.89e-0719020891caeaef78326734c1e31a0c4739190d5c5a77b9e
ToppCellControl-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

FREM1 PROM1 NALCN PXDNL COL27A1 APOE ZFPM2 TGFBR3 PRELP

3.02e-07191208914057205ddb9b4bbc582d1358d13cf36d979a61b
ToppCellRA-09._Endothelium_I|World / Chamber and Cluster_Paper

CDH23 TNFRSF10D ITPKB VWF KALRN DOCK9 APBB2 NRG3 CDH5

3.02e-071912089c8a0c2af119bc34a8f694a7d30642f28002c84b9
ToppCellCOVID-19-kidney-CNT|COVID-19 / Disease (COVID-19 only), tissue and cell type

FREM1 PROM1 FREM2 PTPN3 TFCP2L1 PKHD1 FRAS1 NAALADL2 PLPP4

3.16e-071922089760c6b9628de9693034b00c5025c5c4df94bb2e8
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

PTPN3 TFCP2L1 FAT1 PKHD1 PRUNE2 FRAS1 PCLO CUBN NAALADL2

3.30e-0719320893866667dd221612589ae50f5c52f73a183a49ce6
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PROM1 FREM2 PTPN3 TFCP2L1 FAT1 PKHD1 FRAS1 PCLO NAALADL2

3.45e-07194208993c68c31e39fa44c1d05d7d4997f4f086da4e738
ToppCellLPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ITPKB HECW2 FAT4 VWF DOCK9 APBB2 ZFPM2 MACF1 CDH5

3.45e-0719420890b9cd96fa0b616da7cc90e92ff71157e9bba518f
ToppCellChildren_(3_yrs)-Endothelial|Children_(3_yrs) / Lineage, Cell type, age group and donor

HECW2 FAT4 VWF KALRN DOCK9 ZFPM2 TGFBR3 NRG3 CDH5

3.60e-071952089094cf6591daa5ffad36e44122b6f524a3a34c2fd
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

PROM1 PTPN3 TFCP2L1 FAT1 PKHD1 FRAS1 NAALADL2 PPL UNC13C

3.76e-071962089c7136b1c83bcf907eec3b02b151fa061298b6672
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

PROM1 FREM2 PTPN3 TFCP2L1 FAT1 PKHD1 FRAS1 PCLO NAALADL2

3.76e-0719620896ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

CYP24A1 PTPN3 TFCP2L1 FAT1 PKHD1 PRUNE2 FRAS1 NAALADL2 NRG3

3.92e-0719720897e93a97b5ac5ae2f77a4b3141082a1463fed00dd
ToppCellControl_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type

ITGA2 FAT4 NPR1 VWF DOCK9 JMJD1C GPCPD1 MACF1 CDH5

4.45e-0720020893b97920e1e6e2f09ddba2a861baa9c00c2970f4c
ToppCellmild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

ARID4B BIRC6 SAMD9L GOLGB1 SMCHD1 JMJD1C AKAP9 HELZ2 MACF1

4.45e-07200208912f1685ce8f218433068e090c9d839cd5a1910bf
ToppCellBrain_organoid-organoid_Tanaka_cellReport-10w-Neuroepithelial-Proteoglycan-expressing_cell|10w / Sample Type, Dataset, Time_group, and Cell type.

CYP1B1 PLB1 ITPKB SAMD9L FRAS1 APOE TGFBR3 PRELP SERPINB1

4.45e-07200208907d2133c85e0a4eb8bef653ee15ecd0f1b2bbd44
ToppCellcontrol|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

ERBB2 ITGA2 PTPN3 FAT2 GOLGB1 PCLO PPL AKAP9 AHNAK2

4.45e-07200208997f36d2c197e03d93a1fc59949d77ae90f6e6a9a
ToppCellBrain_organoid-organoid_Tanaka_cellReport-10w-Neuroepithelial|10w / Sample Type, Dataset, Time_group, and Cell type.

CYP1B1 PLB1 ITPKB SAMD9L FRAS1 APOE TGFBR3 PRELP SERPINB1

4.45e-072002089ff0b2675c68e9fc1fa16b3276431f199f3642eac
ToppCellNS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

ERBB2 ITGA2 PTPN3 FAT2 GOLGB1 PCLO PPL AKAP9 AHNAK2

4.45e-072002089ecbe89ff95d046155b984c8c150e0b9e7278f839
ToppCellChildren_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

FAT2 PCDH10 PRUNE2 ZCCHC18 LAMA2 ZFPM2 TGFBR3 PRELP

6.35e-0715320881524557514668f515ac1bbe847611f564b265b42
ToppCellTCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9

CYP1B1 NALCN HECW2 KCNJ8 NRK ATP10A ZFPM2 NRG3

6.67e-071542088511923b27469ea20f8bd82a9ec27119a6e884644
ToppCellAdult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D231|Adult / Lineage, Cell type, age group and donor

OBSCN HECW2 VWF ARHGAP23 KALRN TGFBR3 NRG3 CDH5

1.23e-0616720885af9127bae05768a5164d5708a4ad37edca99324
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

MAP3K4 FASN PCDH10 FAT4 COL27A1 LAMA2 ZFPM2 ICAM5

1.47e-061712088972fab891135bd755d5526cbc5a963200067b0a6
ToppCell3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue

RAPGEF6 TSPYL2 GOLGB1 SMCHD1 AKNA JMJD1C AKAP9 MACF1

1.47e-0617120882e9a20f8980b78325c52065a9c14ab3656267c05
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

MAP3K4 FASN PCDH10 FAT4 COL27A1 LAMA2 ZFPM2 ICAM5

1.47e-0617120882a77ed79c6f2e700e789c80451a70ecb31639719
ToppCellTCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9

HDAC4 NAP1L3 NALCN GOLGB1 MARF1 WDFY3 NRG3 PC

1.90e-061772088e8ab340b20cd41554c3841fe980e078e878af35f
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

ITGA2 FREM1 ITPKB TFCP2L1 NRK FRAS1 APBB2 NAALADL2

2.07e-061792088666072c0e8448dbaec1683d18368ec2502453f90
ToppCellChildren_(3_yrs)-Mesenchymal-myofibroblast_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor

NALCN FAT4 COL27A1 LAMA2 ZFPM2 TGFBR3 PRELP UNC13C

2.16e-06180208801f2e5d96016823482f89ba503d007d4bd88eeac
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

CYP1B1 DCHS2 PROM1 FAT1 NALCN NPR1 ZFPM2 NRG3

2.25e-0618120885f2d3a08577c440c944778d07aa993c6e7873f3d
ToppCell5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

NALCN NRK PRUNE2 FAT4 LAMA2 TGFBR3 PRELP KIAA1755

2.25e-061812088b116c68393d8836bac080f81a8fcbeb52e0403e7
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

CYP1B1 DCHS2 PROM1 FAT1 NALCN NPR1 ZFPM2 NRG3

2.25e-061812088c7c5f7d4c397b4613c772413a0a679377efffff3
ToppCellChildren_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor

DCHS2 HECW2 KALRN DOCK9 ZFPM2 TGFBR3 NRG3 CDH5

2.34e-061822088a20017b6a4f9a6a29e090e4dbd7c02ed1495bd50
ToppCellCOVID-19-kidney-Distal_Epi_Doublet_(PCT)|COVID-19 / Disease (COVID-19 only), tissue and cell type

PROM1 PTPN3 TFCP2L1 PKHD1 PRUNE2 FRAS1 PCLO CUBN

2.34e-0618220889d67717a6e13bcb54c1297a3e4e3abf4e51628a3
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ITGA2 FREM1 ITPKB TFCP2L1 NRK FRAS1 APBB2 UNC13C

2.44e-0618320882e831a4d99c6f983793df71c0994124c943c6da9
ToppCellCOVID-19-kidney-PCT-S1|kidney / Disease (COVID-19 only), tissue and cell type

CYP24A1 FAT1 PKHD1 PRUNE2 SEC16B COL27A1 KIAA1549 CUBN

2.54e-06184208851ed1ebfdef45149541917c66cbacad87072e51f
ToppCellCOVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type

CYP1B1 HMCN2 PXDNL LAMA2 ZFPM2 TGFBR3 PRELP KIAA1755

2.64e-0618520888f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d
ToppCellmetastatic_Lymph_Node-Endothelial_cells-Tumor_ECs|metastatic_Lymph_Node / Location, Cell class and cell subclass

KIF17 SEC16B FAT4 NPR1 VWF DOCK9 LRRC1 CDH5

2.86e-0618720882713f526f86911fbbf6c7a3e69230f2e6bde31c3
ToppCellCOVID-19-kidney|COVID-19 / Disease (COVID-19 only), tissue and cell type

PROM1 PTPN3 TFCP2L1 PKHD1 PRUNE2 FRAS1 PCLO CUBN

2.86e-061872088d23aae9419d460b78b1d4092d7acd9108a47cfbe
ToppCellCOVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type

CYP1B1 FREM1 HMCN2 LAMA2 ZFPM2 TGFBR3 PRELP KIAA1755

2.98e-061882088fe361215f4ba841aa5e1e581fb56f2f4d3ccd201
ToppCellCOVID-19-lung-Vein_EC|lung / Disease (COVID-19 only), tissue and cell type

HECW2 VWF KALRN DOCK9 ZFPM2 TGFBR3 LRRC1 NRG3

2.98e-061882088d582b76fc2faac526c9bf97503041129e1a6a211
ToppCellCOVID-19-kidney-DCT|kidney / Disease (COVID-19 only), tissue and cell type

ITGA2 ITPKB PTPN3 TFCP2L1 NRK PKHD1 APBB2 NAALADL2

2.98e-061882088df1fd0819d301679f3c9ea404e942e39095912eb
ToppCellControl-Endothelial_cells|Control / group, cell type (main and fine annotations)

HECW2 VWF KALRN DOCK9 TGFBR3 ITPRIP NRG3 CDH5

2.98e-0618820883953b08abfea93468fc8d177bdb16ca7c6ffa1ab
ToppCellPCW_13-14-Endothelial-Endothelial_mature-endo_bronchial_(8)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

TNFRSF10D ITGA2 KIF17 NPR1 VWF DOCK9 NRG3 CDH5

2.98e-061882088986aaf31161ec3d1e6c76ee2dd17f44848a21f7e
ToppCellControl-Endothelial-VE_Venous|World / Disease state, Lineage and Cell class

NPR1 VWF ARHGAP23 KALRN ZFPM2 LRRC1 NRG3 CDH5

3.10e-061892088f83f7521e377ded1522639e9a35c98b3e2725bac
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

PROM1 FAT1 PKHD1 DNAH6 PRUNE2 NPR1 PPL WDFY3

3.10e-061892088904b8337e2cabac2f0bf5dad5598fc429581ed81
ToppCellrenal_cortex_nuclei-Adult_normal_reference|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group

MON2 ACACB TSPYL2 TFCP2L1 GOLGB1 MGAM FRAS1 KIAA1549

3.10e-061892088a48df46274d51e84ffb40264646de7346104efb9
ToppCellCOVID-19-kidney-PCT-S2|kidney / Disease (COVID-19 only), tissue and cell type

CYP24A1 FAT1 PKHD1 PRUNE2 COL27A1 CUBN NRG3 SAMD4A

3.10e-0618920880be5c669b6b308bd98ddb70c84877c62a6244bbd
ToppCellmegakaryocytic-CD34+_Megakaryoblast|World / Lineage and Cell class

MORC1 ITGA2 ITGA2B VWF KALRN ZFPM2 GAS2L1 SLC18A2

3.22e-0619020881d19b2bd55789bf13e1386332f46c605973d6f8e
ToppCellPCW_07-8.5-Epithelial-Epithelial_airway-epi_intermediate_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

KREMEN1 FREM2 PKHD1 FRAS1 PCLO PPL OCLN PLCH1

3.22e-061902088c95032bb3ee2b3d40fdf48016acb46d6f78a48a6
ToppCellChildren_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

HECW2 FAT4 KALRN DOCK9 ZFPM2 TGFBR3 NRG3 CDH5

3.22e-0619020880e9847d7f49b2236b8a191e1a7df37556351ba9e
ToppCellIPF-Endothelial-Lymphatic|World / Disease state, Lineage and Cell class

PTPN3 HECW2 KALRN DOCK9 ZFPM2 LRRC1 NRG3 CDH5

3.22e-061902088ac029e73da5995221c9b9af551d85e4b835e21d6
ToppCelldroplet-Heart-HEART-1m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FREM1 NRK IGSF3 VWF PPL SLC18A2 LRRC1 OCLN

3.35e-0619120884bfdf44d4402a42530d30c89d94946acdda4321b
ToppCellLV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper

ACACB OBSCN PXDNL MYO18B LAMA2 CCDC141 ZFPM2 SAMD4A

3.35e-06191208825f3eb34f4e70761e81e84c8a5829f216108cbc6
ToppCellCD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster

MON2 BIRC6 SMCHD1 HUWE1 GPCPD1 MACF1 TYW1 POLQ

3.35e-0619120889454f642c3621370fa23640b631301346b300950
ToppCellCOVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type

FREM2 PTPN3 FASN TFCP2L1 PCLO CCDC141 NAALADL2 PLCH1

3.35e-061912088276455a64c2c3503d5048615762eb2ee37f0ac70
ToppCellChildren_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Children_(3_yrs) / Lineage, Cell type, age group and donor

HECW2 FAT4 KALRN DOCK9 ZFPM2 TGFBR3 NRG3 CDH5

3.35e-061912088f229abf69a1217194f74b0502486907e07dba989
ToppCellRA-09._Endothelium_I|RA / Chamber and Cluster_Paper

CDH23 ITPKB VWF KALRN DOCK9 APBB2 NRG3 CDH5

3.48e-0619220888a1b1c3e83a68ad74f8f4eb00455c9e41aa57cfc
ToppCellIPF-Endothelial-Lymphatic|IPF / Disease state, Lineage and Cell class

PTPN3 HECW2 KALRN DOCK9 ZFPM2 LRRC1 NRG3 CDH5

3.48e-0619220882496edd8f3a41146d418879de9ee2ccc7857431f
ToppCellControl-Endothelial-Lymphatic|World / Disease state, Lineage and Cell class

PTPN3 HECW2 ARHGAP23 KALRN ZFPM2 LRRC1 NRG3 CDH5

3.48e-061922088f95fb188aa642f3d0618242a770e7c4b70544adb
ToppCellPCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

KREMEN1 FREM2 PKHD1 FRAS1 PCLO PPL OCLN PLCH1

3.48e-061922088b99f8236ef4ccdc75c02abea381cae6453205f6f
ToppCellnucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

VWF KALRN DOCK9 ZFPM2 TGFBR3 LRRC1 NRG3 CDH5

3.62e-0619320889ba688b35a9ead5d04691b3f3f15484f02dbbd0d
ToppCellControl-Endothelial-Endothelial-Gen_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ITGA2 ITPKB HECW2 FAT4 VWF DOCK9 GPCPD1 CDH5

3.62e-061932088e1d546165dcc2392f540162206852c4717d7306f
ToppCellCOPD-Endothelial-Lymphatic|World / Disease state, Lineage and Cell class

PTPN3 HECW2 ARHGAP23 KALRN DOCK9 ZFPM2 LRRC1 CDH5

3.62e-06193208825bdc557055b5bce6a21f8696b48e991c696b979
ToppCellCOPD-Endothelial-Lymphatic|COPD / Disease state, Lineage and Cell class

PTPN3 HECW2 ARHGAP23 KALRN DOCK9 ZFPM2 LRRC1 CDH5

3.62e-06193208818bcf08068a236c4575c7a07181ac893dfdcbeeb
ToppCellControl-Endothelial-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ITPKB HECW2 FAT4 NPR1 VWF DOCK9 PHACTR4 CDH5

3.62e-061932088aff0649c73c634bc6ff0dc7759b4693a9236bf05
ToppCellControl-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ITPKB HECW2 FAT4 NPR1 VWF DOCK9 PHACTR4 CDH5

3.62e-061932088c5f9fe03e64c211d4bcd4959e5b32f14841e336a
ToppCellIPF-Endothelial-VE_Venous|IPF / Disease state, Lineage and Cell class

NPR1 VWF KALRN DOCK9 TGFBR3 LRRC1 NRG3 CDH5

3.62e-06193208829a655fa80feaabe846c90a28363b037e22d24ae
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

ITGA2 FREM2 PTPN3 TFCP2L1 FAT1 PKHD1 FRAS1 PCLO

3.76e-0619420885eaaa81f4b2535f983c424aaef00077089526a5c
ToppCellPCW_07-8.5-Epithelial|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

KREMEN1 FREM2 PKHD1 FRAS1 PCLO PPL OCLN PLCH1

3.76e-061942088f63ceedb88a9abc8644ee94adfd541e7817c1e3a
ToppCellChildren_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

OBSCN HECW2 FAT4 VWF DOCK9 KIAA1549 TGFBR3 CDH5

3.76e-06194208840842a7160f337bfc191ee15fbda3e3d38a04c57
ToppCellControl-Endothelial|Control / Disease state, Lineage and Cell class

HECW2 VWF ARHGAP23 KALRN DOCK9 ZFPM2 NRG3 CDH5

3.76e-061942088485fe5538fabec457b9a51feb641f2a91cbf4e18
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

PTPN3 TFCP2L1 FAT1 PKHD1 PRUNE2 FRAS1 CUBN PHACTR4

3.76e-0619420887002937e8903e037332a215d00fbc7c7843b33f2
ToppCellbackground-Endothelial_cells|World / Sample and Cell Type and Tumor Cluster (all cells)

HECW2 NPR1 VWF KALRN TGFBR3 ITPRIP NRG3 CDH5

3.90e-061952088c7d60dabfc7cb310e002cab10003dadfcc34fe33
ToppCellproximal-Endothelial-Vein|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

CYP1B1 TNFRSF10D FAT4 VWF TYW1B ITPRIP CDH5 NEURL4

3.90e-0619520880aebdd635a956dd2367883c1cf73d73ce9790635
ToppCell3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ITGA2 NUDT8 FAT2 ARHGAP23 ARHGEF5 PPL SERPINB1 AHNAK2

3.90e-06195208824d226f89dd337c22728688e4b40ca082a0e1fe1
ToppCellCOVID-19-kidney-PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type

ITPKB VWF KALRN SMCHD1 DOCK9 ITPRIP MACF1 CDH5

3.90e-061952088a436483fec137584611f86b7a498a4dc2aa19cd3
ToppCellproximal-3-Endothelial-Vein|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

CYP1B1 TNFRSF10D FAT4 VWF TYW1B ITPRIP CDH5 NEURL4

3.90e-061952088c81eb541c15b866f9b6ca6a5f1751c5f1243f4fb
ToppCellproximal-Endothelial-Vein-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

CYP1B1 TNFRSF10D FAT4 VWF TYW1B ITPRIP CDH5 NEURL4

3.90e-061952088df00f94facc5d6107aac83cef3c64fefc7f8e562
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

ITGA2 PROM1 PTPN3 TFCP2L1 PKHD1 FRAS1 PCLO NAALADL2

3.90e-0619520886477e6e7be5bd8eb99119a12ae16334ccddecd43
ToppCelldroplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CYP1B1 ZBTB38 LAMA2 CHD9 JMJD1C TGFBR3 AKAP9 PRELP

3.90e-0619520885c86fddd6d0530beecf45ea5ba6b823123847696
ToppCellControl-Epithelial_alveolar-AT_1-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

PLB1 TSPYL2 NAP1L3 CUBN PPL NEURL4 AHNAK2

3.96e-061382087611fe0fb284e12678f9c47a0bdbfc367a93c52b3
Drugirinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A

ARID4B RNF216 EHBP1 DOCK9 APBB2 AMBRA1 CHD9 JMJD1C LRRC1 WDFY3 PLCH1

5.93e-07174207117530_DN
DrugN-ethyl-N-nitrosourea

MTA2 ERBB2 ABCA12 CCNO ITGA2B MAP3K4 ITPKB KCNJ8 VWF SMCHD1 ZFPM2 NRG3 POLQ

1.53e-0627520713CID000012967
Diseasevenous thromboembolism, fibrinogen measurement

DCHS2 RAPGEF6 VWF CHD9 DGKZ JMJD1C ZFPM2

4.17e-07672047EFO_0004286, EFO_0004623
DiseaseFraser syndrome (implicated_via_orthology)

FREM1 FREM2 FRAS1

1.30e-0642043DOID:0090001 (implicated_via_orthology)
Diseasevon Willebrand's disease 1 (is_implicated_in)

ITGA2 ITGA2B VWF

1.30e-0642043DOID:0060573 (is_implicated_in)
Diseaseurate measurement, bone density

PLB1 ACTR5 FREM1 ITPKB FSIP2 A2ML1 SEC16A VWA3B USH2A FRAS1 NAALADL2 PPL DNAH1 HELZ2 KIAA1755 PRKAR2A CDH12

1.64e-0661920417EFO_0003923, EFO_0004531
DiseaseUnilateral agenesis of kidney

FREM1 FREM2 FRAS1

1.78e-0582043C0266294
Diseaseplatelet component distribution width

KREMEN1 ITGA2 ITGA2B ZPR1 CCDC40 PRUNE2 VWF KALRN DOCK9 APOE CUBN JMJD1C ZFPM2 ADO TLN1 MACF1 SLC12A7

2.20e-0575520417EFO_0007984
Diseasecholesterol:total lipids ratio, high density lipoprotein cholesterol measurement

ACACB BIRC6 RMI1 ZPR1 SEC16B APOE JMJD1C DNAH1 TYW1B MACF1

2.44e-0527620410EFO_0004612, EFO_0020943
Diseaseomega-6:omega-3 polyunsaturated fatty acid ratio

ZPR1 DAGLA APOE JMJD1C NRG3

2.47e-05502045EFO_0010732
Diseasevon Willebrand's disease 2 (is_implicated_in)

ITGA2 VWF

4.76e-0522042DOID:0060574 (is_implicated_in)
DiseaseMarles Greenberg Persaud syndrome

FREM1 FREM2

4.76e-0522042C1855425
DiseaseMalignant neoplasm of breast

CYP1B1 ERBB2 HDAC4 CYP24A1 OBSCN FASN BRCA1 MROH7 GOLGB1 EHBP1 VWF KALRN LAMA2 PANX2 CUBN AKAP9 ICAM5 MACF1 OCLN CDH5

6.09e-05107420420C0006142
DiseaseDisorder of eye

CYP1B1 CDH23 FREM1 PROM1 FREM2 USH2A TCTN1 FRAS1

1.21e-042122048C0015397
DiseaseProteinuria

VWF CUBN UNC13C

1.39e-04152043HP_0000093
DiseaseGlanzmann's thrombasthenia (is_implicated_in)

ITGA2 ITGA2B

1.42e-0432042DOID:2219 (is_implicated_in)
DiseaseCryptophthalmos syndrome

FREM2 FRAS1

1.42e-0432042C0265233
Diseaseprotocadherin beta-10 measurement

ZPR1 APOE

1.42e-0432042EFO_0801974
DiseaseFRASER SYNDROME 1

FREM2 FRAS1

1.42e-0432042C4551480
Diseasevery low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio

ZPR1 SEC16A SEC16B APOE JMJD1C TYW1B HELZ2 MACF1

1.66e-042222048EFO_0008317, EFO_0020943
Diseasetriglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement

ZPR1 SEC16A SEC16B APOE JMJD1C TYW1B HELZ2 MACF1

1.82e-042252048EFO_0008317, EFO_0020947
Diseasedepressive symptom measurement

CAAP1 ACTR5 PKHD1 DAGLA EHBP1 VWF PCLO PCDHA6 MSH5 NAALADL2 PRKAR2A

2.01e-0442620411EFO_0007006
Diseasemean platelet volume

ZBTB38 MYO5A CYP24A1 ITGA2 ITGA2B ZPR1 VWF PCDHGB7 PCDHGB5 KALRN PCDHGB3 CHD9 JMJD1C TFAP4 ZFPM2 ITPRIP SLC12A7 PCDHGC3

2.77e-04102020418EFO_0004584
Diseasedihydrofolate reductase measurement

VWF APOE

2.83e-0442042EFO_0801526
Diseasecoronary artery disease (implicated_via_orthology)

KCNJ8 APOE

2.83e-0442042DOID:3393 (implicated_via_orthology)
Diseaseneutrophil-activating peptide 2 measurement

JMJD1C ZFPM2

2.83e-0442042EFO_0020606
Diseaseoleoyl-oleoyl-glycerol (18:1/18:1) [2] measurement

ZPR1 APOE

2.83e-0442042EFO_0800498
Diseasecongenital diaphragmatic hernia (is_implicated_in)

FREM1 ZFPM2

2.83e-0442042DOID:3827 (is_implicated_in)
Diseasecholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement

ACACB RMI1 ZPR1 APOE JMJD1C DNAH1 TYW1B MACF1

3.06e-042432048EFO_0004612, EFO_0020944
Diseasecholesteryl esters to total lipids in small VLDL percentage

ZPR1 SEC16A APOE JMJD1C

3.68e-04492044EFO_0022256
Diseasecognitive inhibition measurement

TGM6 PXDNL A2ML1 USH2A

3.98e-04502044EFO_0007969
Diseasegestational age

ZBTB38 VWA3B COL27A1 NAALADL2 TFAP4 TGFBR3

4.09e-041382046EFO_0005112
Diseaseretinal drusen

ITGA2 VWF LARP1B UNC13C

4.30e-04512044EFO_1001155
Diseasemuscular disease (implicated_via_orthology)

ACACB FASN

4.69e-0452042DOID:0080000 (implicated_via_orthology)
Diseaselinoleoyl-linoleoyl-glycerol (18:2/18:2) [1] measurement

ZPR1 APOE

4.69e-0452042EFO_0800510
Diseaselow density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio

ACACB ZPR1 APOE JMJD1C DNAH1 TYW1B MACF1

5.06e-042002047EFO_0004611, EFO_0020945
Diseasevenous thromboembolism, tissue plasminogen activator measurement

VWF DGKZ ZFPM2

5.21e-04232043EFO_0004286, EFO_0004791
Diseasevery low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio

ZPR1 SEC16A SEC16B APOE JMJD1C TYW1B HELZ2 MACF1

5.30e-042642048EFO_0008317, EFO_0020944
Diseasetriglyceride measurement, phospholipid measurement

ACACB ZPR1 APOE JMJD1C DNAH1 TYW1B

5.51e-041462046EFO_0004530, EFO_0004639
Diseasecomplex trait

ZBTB38 FREM1 ZPR1 APOE CCDC141 ADO KIAA1755 MACF1

6.29e-042712048EFO_0010578
Diseasetriglycerides:total lipids ratio, low density lipoprotein cholesterol measurement

RMI1 ZPR1 APOE JMJD1C TYW1B MACF1

6.36e-041502046EFO_0004611, EFO_0020947
DiseaseFNAITP

ITGA2 ITGA2B

7.01e-0462042C3854603
DiseaseNeonatal Alloimmune Thrombocytopenia

ITGA2 ITGA2B

7.01e-0462042C3853779
Diseasegamma-enolase measurement

JMJD1C ZFPM2

7.01e-0462042EFO_0021845
DiseaseColorectal Neoplasms

CALCOCO2 CYP1B1 ABCA12 PROM1 CABYR FAT1 ICAM5 CDH5

7.25e-042772048C0009404
Diseaseglycerol measurement

FAT4 PCLO NPRL3

7.53e-04262043EFO_0010115
Diseaselung carcinoma (is_implicated_in)

CYP24A1 APOE

9.76e-0472042DOID:3905 (is_implicated_in)
DiseaseX-24870 measurement

ZPR1 APOE

9.76e-0472042EFO_0022143
Diseasegrapefruit juice consumption measurement

PCLO DCP1B

9.76e-0472042EFO_0010094
Diseasevitamin k-dependent protein S measurement

COL27A1 AKNA

9.76e-0472042EFO_0020850
Diseasetotal cholesterol measurement, very low density lipoprotein cholesterol measurement

ACACB MAP3K4 ZPR1 EHBP1 APOE TYW1B GPCPD1

9.85e-042242047EFO_0004574, EFO_0008317
Diseasecarcinoma (implicated_via_orthology)

ERBB2 FAT4 LRRC1 SCRIB

1.02e-03642044DOID:305 (implicated_via_orthology)
DiseaseCiliopathies

CDH23 PKHD1 USH2A TCTN1 CCDC40

1.02e-031102045C4277690
Diseasecholesteryl ester measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement

ACACB ZPR1 APOE JMJD1C TYW1B

1.02e-031102045EFO_0008317, EFO_0008596, EFO_0010351
Diseasefree cholesterol measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement

ACACB ZPR1 APOE JMJD1C TYW1B

1.02e-031102045EFO_0008317, EFO_0008591, EFO_0008596
Diseasechylomicron measurement, total cholesterol measurement, very low density lipoprotein cholesterol measurement

ACACB ZPR1 APOE JMJD1C TYW1B

1.02e-031102045EFO_0004574, EFO_0008317, EFO_0008596
Disease1,5 anhydroglucitol measurement

MGAM SI PCDHA6

1.04e-03292043EFO_0008009
Diseasevery low density lipoprotein cholesterol measurement, phospholipid measurement

ACACB MAP3K4 ZPR1 EHBP1 APOE TYW1B GPCPD1

1.12e-032292047EFO_0004639, EFO_0008317
Diseasefactor XI measurement, venous thromboembolism

VWF DGKZ ZFPM2

1.15e-03302043EFO_0004286, EFO_0004694
Diseaseimmature platelet fraction

VWF KALRN JMJD1C ZFPM2 SLC12A7

1.20e-031142045EFO_0009187
Diseasephospholipids:total lipids ratio, intermediate density lipoprotein measurement

ZPR1 APOE JMJD1C MACF1

1.21e-03672044EFO_0008595, EFO_0020946
Diseaseelectrocardiography

OBSCN PROM1 PTPN3 HMCN2 MYO18B CCDC141 JMJD1C ZFPM2 NPRL3 KIAA1755 CDH17

1.23e-0353020411EFO_0004327
Diseasecholesteryl esters to total lipids in large LDL percentage

ZPR1 APOE JMJD1C

1.27e-03312043EFO_0022249
DiseaseColorectal Carcinoma

CALCOCO2 CYP1B1 ABCA12 OBSCN PROM1 CABYR FAT1 PKHD1 KALRN CUBN AKAP9 ICAM5 CDH5

1.28e-0370220413C0009402
DiseaseBenign Neoplasm

BIRC6 FASN BRCA1 OCLN

1.28e-03682044C0086692
DiseaseNeoplasms

BIRC6 FASN BRCA1 OCLN

1.28e-03682044C0027651
Diseasechylomicron measurement, very low density lipoprotein cholesterol measurement, esterified cholesterol measurement

ZPR1 APOE

1.30e-0382042EFO_0008317, EFO_0008589, EFO_0008596
Diseasebenign neoplasm (implicated_via_orthology)

LRRC1 SCRIB

1.30e-0382042DOID:0060072 (implicated_via_orthology)
DiseaseDickkopf-related protein 4 measurement

JMJD1C ZFPM2

1.30e-0382042EFO_0008110
Diseaseomega-3 polyunsaturated fatty acid measurement

ZPR1 DAGLA APOE JMJD1C TYW1B

1.40e-031182045EFO_0010119
Diseaseimmature platelet measurement

VWF KALRN JMJD1C ZFPM2 SLC12A7

1.45e-031192045EFO_0803541
Diseasechildhood trauma measurement, alcohol consumption measurement

PCDHGB7 PCDHGB5 PCDHGB3 PCDHGC3

1.50e-03712044EFO_0007878, EFO_0007979
Diseaseplatelet measurement

GLB1L ITGA2B VWF KALRN CHD9 JMJD1C ZFPM2 SLC12A7

1.65e-033152048EFO_0005036
DiseaseDCN1-like protein 5 measurement

ZPR1 APOE

1.66e-0392042EFO_0801520
Diseasediacylglycerol 36:4 measurement

ZPR1 APOE

1.66e-0392042EFO_0020063
Diseasevascular endothelial growth factor A, isoform 121 measurement

JMJD1C ZFPM2

1.66e-0392042EFO_0020847
Disease22q11 partial monosomy syndrome

JMJD1C SEC24C

1.66e-0392042C3266101
Diseaseglucose metabolism decline measurement, cingulate cortex measurement

CDH23 TYW1

1.66e-0392042EFO_0007738, EFO_0009392
Diseasefactor VIII measurement, venous thromboembolism

VWF DGKZ ZFPM2

1.66e-03342043EFO_0004286, EFO_0004630
Diseasepuberty onset measurement

BIRC6 RMI1 SEC16B JMJD1C TFAP4

1.80e-031252045EFO_0005677
DiseaseKartagener Syndrome

CCNO CCDC40 DNAH1

1.81e-03352043C0022521
DiseaseCiliary Dyskinesia, Primary, 1, With Or Without Situs Inversus

CCNO CCDC40 DNAH1

1.81e-03352043C4551906
DiseasePolynesian Bronchiectasis

CCNO CCDC40 DNAH1

1.81e-03352043C4317124
Diseaseresponse to alcohol

WWC2 PKHD1 LAMA2 NAALADL2

1.84e-03752044EFO_0005526
Diseasealkaline phosphatase measurement

CALCOCO2 ACACB CYP24A1 ITPKB PRR14 KIF17 GOLGB1 SEC16B LARP1B APOE JMJD1C TFAP4 PPL TTC7A MACF1 UNC13C

1.94e-03101520416EFO_0004533
DiseasePrimary ciliary dyskinesia

CCNO CCDC40 DNAH1

1.97e-03362043cv:C0008780
DiseaseMalignant Neoplasms

ERBB2 BIRC6 FASN BRCA1 OCLN

2.00e-031282045C0006826
Disease1,7-dimethylurate measurement

ITGA2 NAALADL2

2.06e-03102042EFO_0021512
Diseaseestrogen measurement

SLC22A25 DAGLA

2.06e-03102042EFO_0011007
DiseaseAsymmetric crying face association

JMJD1C SEC24C

2.06e-03102042C0431406
DiseaseCXCL5 measurement

JMJD1C ZFPM2

2.06e-03102042EFO_0009422
DiseaseC-X-C motif chemokine 5 measurement

JMJD1C ZFPM2

2.06e-03102042EFO_0008058
Diseasequinone oxidoreductase-like protein 1 measurement

ZPR1 APOE

2.06e-03102042EFO_0021880
Diseaseoleoyl-linoleoyl-glycerol (18:1/18:2) [2] measurement

ZPR1 APOE

2.06e-03102042EFO_0800333
Disease22q11 Deletion Syndrome

JMJD1C SEC24C

2.06e-03102042C2936346
DiseasePR interval

ABCA12 OBSCN FREM2 FAT1 KALRN TFAP4 ZFPM2 KIAA1755 MACF1 SLC12A7

2.47e-0349520410EFO_0004462
Diseasedegree of unsaturation measurement

ZPR1 APOE JMJD1C

2.48e-03392043EFO_0022261
Diseasecytochrome p450 3a4 measurement

ZPR1 APOE

2.51e-03112042EFO_0020303
Diseasecoagulation factor XA measurement

COL27A1 AKNA

2.51e-03112042EFO_0020266
DiseasePancreatic Ductal Adenocarcinoma

ACACB ABCA12

2.51e-03112042C1335302
Diseasekidney cancer (implicated_via_orthology)

LRRC1 SCRIB

2.51e-03112042DOID:263 (implicated_via_orthology)
Diseaseoleoyl-linoleoyl-glycerol (18:1/18:2) [1] measurement

ZPR1 APOE

2.51e-03112042EFO_0800332

Protein segments in the cluster

PeptideGeneStartEntry
EIEPFPEERENFLQQ

ARID4B

301

Q4LE39
PLQPEQLQVFETLEE

ERBB2

391

P04626
EQQLKVVPRFQPISE

AKAP9

2091

Q99996
RANVNLDVPLQVDFP

APBB2

566

Q92870
EQAVETEPEPELRQQ

APOE

21

P02649
DVQTPLIIQPEQRNV

BIRC6

806

Q9NR09
PAQPVAQLDLQTFRD

CCNO

86

P22674
LEDQEENPLPAALVQ

PGLS

216

O95336
EPALNPLANRQQITE

ACTRT3

106

Q9BYD9
QQFEPPLQPREREAV

ADO

151

Q96SZ5
IPIPDNRAEIISQVF

ABCA12

586

Q86UK0
FPVQQVEFISNPEVR

ARHGEF5

1561

Q12774
SQINPDLVREFPDVL

GCLM

56

P48507
VEITLQDINDNPPVF

FAT4

1726

Q6V0I7
ISIRPIPEENFLAAQ

A4GNT

171

Q9UNA3
VNRLVFQQDTLPNVP

A2ML1

1281

A8K2U0
PDTFRDQLQELCIPQ

COMMD5

106

Q9GZQ3
QLPEQIVIPFTDQVA

CABYR

311

O75952
SPFDRNVPVNLELQE

ACTR5

96

Q9H9F9
PEDVQPSAQQLELLE

CAAP1

326

Q9H8G2
LQNAETQTEREVPEP

AMBRA1

1111

Q9C0C7
EDPQERPPFQQIRLT

NPR1

786

P16066
ITDQPPLVQAIFSRD

ANKRD52

6

Q8NB46
QPLRIQAQDPEFSDL

CDHR5

381

Q9HBB8
INITDVDEPPIFQQP

CDH5

361

P33151
DINDSRPEFLNPIQT

CDH23

2166

Q9H251
LDRDVPANVLLTNPQ

ATP10A

1141

O60312
LQATVQEVQPRAEEP

AIRE

341

O43918
PVSPCQNILRVIEEF

MROH7

671

Q68CQ1
QLENQPSEFRRIESP

RAE1

196

P78406
PSLTQQQFEELVRPF

RAVER1

141

Q8IY67
LTQPIEFVPEDEIQR

RBM41

271

Q96IZ5
PDNPLTDRQIDQFLV

MTA2

181

O94776
LLFPRENATVPENEE

ITPRIP

21

Q8IWB1
VQELPLTSPVDDFRQ

OCLN

351

Q16625
PQSLRPNSEEVDEVF

NUDT8

126

Q8WV74
RVRFFIPDPNTLQQE

PTPN3

106

P26045
AQIRILVIDANDNPP

PCDHGB7

226

Q9Y5F8
INDNPPLFPVEEQRV

PCDHA6

126

Q9UN73
ESRFQVQTVLQFVPP

KIAA1549

1041

Q9HCM3
RLAEQQPQPQFIPVD

MORC1

561

Q86VD1
EDFPILFRQVQSEIP

ACACB

471

O00763
QPNIFEILQERQPDL

HECW2

1091

Q9P2P5
QQLEESRIPDQDTIP

NRG3

511

P56975
VIVSVLDINDNPPVF

FAT1

3216

Q14517
DQQLPVFQVTAPRLA

FRAS1

1591

Q86XX4
LDIPVDNPIESNNIF

KCNJ8

246

Q15842
QFSLPVAEPALREQQ

HDAC4

56

P56524
VEPGQRQPSEQELLF

HDAC4

576

P56524
PIPRISQAEEEDQQL

HINT2

96

Q9BX68
EAVQQLQPPEDGLFL

MATK

131

P42679
VQPVQPEEVSARDFL

LYSMD2

166

Q8IV50
ITSPEFVDDRPQVVN

KIAA1755

181

Q5JYT7
ADRNFTLQVQVPPVL

HMCN2

3401

Q8NDA2
ILVLQSAPVFQVEPQ

HMCN2

4296

Q8NDA2
VESVLNRVPQPEYRQ

PHKA1

1111

P46020
PVVNELERINCIPDQ

MGAM

91

O43451
FVDPVLNQLQRPPQE

JMJD1C

996

Q15652
RQFFPIVIIPTNDEQ

FREM2

1176

Q5SZK8
QRPPLVQQRFLDVAN

ZFPM2

751

Q8WW38
PIAPIIRNILNEIFQ

FSIP2

1776

Q5CZC0
DQVFPIAREEAPINL

PCLO

2841

Q9Y6V0
VRVSIEDVNDNPPKF

FAT2

2056

Q9NYQ8
VVNVSDINDNPPEFR

FAT2

2366

Q9NYQ8
QLVDIREPETQPVCF

ICAM5

86

Q9UMF0
LENLRFPNNVEPVTN

IPO7

801

O95373
QFEEQPVENLFPELT

KPTN

181

Q9Y664
VPDPVLEESFQQLQR

PPL

941

O60437
LEEFRQTQQVPPNKI

NAA16

171

Q6N069
EFRNPLAPAVQETQL

NPRL3

376

Q12980
FNITILPVDNQVPEA

FREM1

766

Q5H8C1
LNPNFIQEVAPEFLV

KALRN

2461

O60229
PQERPAVNQTVAEVI

KREMEN1

326

Q96MU8
RIRVAPQQDDLDSPQ

LAMA2

551

P24043
IPPDNLSIQEFQRNE

MON2

1506

Q7Z3U7
TELRIQVTDANDNPP

PCDHGB5

226

Q9Y5G0
TQIRVIVADANDNPP

PCDHGB3

226

Q9Y5G1
TIVRVQVSDINDNPP

PCDHGC3

441

Q9UN70
FQVEIEVLDINDNPP

PCDH10

106

Q9P2E7
PPAIQEEVLAQQRAE

HUWE1

3026

Q7Z6Z7
LDVRQIPAAQEQPFI

ITGA2

801

P17301
QVVDERVLVFNPEEP

KIF18B

31

Q86Y91
QRPTPEELEQRNILQ

PHACTR4

591

Q8IZ21
TEFLDPFQRVIQPEE

PLPP4

21

Q5VZY2
LSDNEIQRLPPEIAN

LRRC1

66

Q9BTT6
LIQRDQEPIPQNIDR

MACF1

6901

Q9UPN3
RVLDVNDNPPVFSQD

DCHS2

2436

Q6V1P9
AENLEAQPQSTVRPE

PPIG

261

Q13427
EQQEARAESPLPQVS

OBSCN

7236

Q5VST9
PEEVLQRVNVQPELV

RABGGTB

316

P53611
PQVPQQTTVLDLRFN

PXDNL

46

A1KZ92
FVTEPQIIQERPLTN

BRCA1

486

P38398
LEEQNRQEPLIPVEQ

BTBD19

236

C9JJ37
LAAPPETRIQLQFED

CUBN

2251

O60494
EQQTPLFQVISPQRI

DCP1B

501

Q8IZD4
TNLEPRFIEPQTANL

DNAH1

3646

Q9P2D7
NQFIRPVENVSDPVT

CHRNA6

46

Q15825
LVDPNIFIQPITEER

CHD9

1906

Q3L8U1
VVDQPDLDPQFVREF

CDHR2

231

Q9BYE9
LESIFNAPDIQRQLP

DNAH6

1111

Q9C0G6
EPVEFRCILEAQNVP

IGSF3

296

O75054
PEQPNIFQVEQLERL

GPCPD1

616

Q9NPB8
NKFIAPSVPQQEERI

CCDC141

1056

Q6ZP82
NVQRINVRDVSPFPV

DOCK9

1176

Q9BZ29
IQSVLPENQVPRAED

CYP24A1

356

Q07973
SIFRTPLQLDPQQEQ

GAS2L1

501

Q99501
RITFTEPNIQNVPRD

POLQ

2241

O75417
PREGDLPVFQDQIQQ

CCDC40

236

Q4G0X9
ELEDVPLQPQVQFLD

GLB1L

606

Q6UWU2
ITRVPQEFQTPEQAT

AKNA

426

Q7Z591
IPFQFRPENEEDILV

CALCOCO2

121

Q13137
RTQDPQQLPIISVDN

COL27A1

1826

Q8IZC6
PNNLVNPVQELETER

EHBP1

381

Q8NDI1
QSADLIQFEERPQEP

MARF1

1646

Q9Y4F3
QEILLRAQFEPNLVP

DAGLA

956

Q9Y4D2
VLRQQPPDLVEFAVE

PRKAR2A

21

P13861
QPQQTLATEPRENVI

CDH12

26

P55289
PNPVRTVFREFEQLN

CYP1B1

251

Q16678
PENLDFIEVNVSLPR

SERPINB1

261

P30740
DQQPVPEQLRIQVSR

DGKZ

636

Q13574
LVDSFLQQDPAQPVV

FKRP

66

Q9H9S5
PEARLVLEVQFQIDP

HELZ2

461

Q9BYK8
SAPRRQQEQQVPILE

FASN

1101

P49327
PSPVTVFEVQENERL

CDH17

341

Q12864
PETRNQPLLDSIQDV

SLC22A25

516

Q6T423
IPSPIQVIEDDRNNR

SEC24C

326

P53992
PRENSPFLNNVEVEQ

SLC12A7

46

Q9Y666
DQPQEESEEQPVFRL

SAAL1

231

Q96ER3
QQPPEDRTQDVLAQD

CEP131

421

Q9UPN4
QPLVPQLLVQVRIDF

NEURL4

1166

Q96JN8
ENLTPELPFEPNQEV

LARP1B

526

Q659C4
APQQILIATFDEPRT

PANX2

656

Q96RD6
DPLPVVDQQQVLARL

KIF17

731

Q9P2E2
DARRNVPQNDPVTVV

MNDA

201

P41218
NRFTVLPNIDPEIDE

MSH5

391

O43196
VPEIRQPIDNSFDIQ

MAP3K4

471

Q9Y6R4
EEPESLRVNAQVFLP

NRK

576

Q7Z2Y5
IIQFFSPQPTEIRIQ

USH2A

386

O75445
QLDREQFNPDVITFP

DROSHA

756

Q9NRR4
DLEPNEVRLEQQSVP

XAB2

831

Q9HCS7
DFSNPSDIPDQVIRV

RAPGEF6

741

Q8TEU7
RVGVPFNIPLEFQDE

SMCHD1

836

A6NHR9
NLPPREDIINVLQET

PRUNE2

201

Q8WUY3
IPNNSNENIPRVTDV

RMI1

221

Q9H9A7
LQRLPQAEPVEIVAF

SMIM5

21

Q71RC9
EPRFVEVLLQNNTPS

SAMD9L

286

Q8IVG5
LQPPEALVERQGQFL

ITPKB

336

P27987
PERNFVLPEEIIQEV

MRGBP

101

Q9NV56
IDETPNFIIPAQRAE

PRR14

171

Q9BWN1
PPVDAELDNVNNVLR

PROM1

336

O43490
DQLPAFIQIDLQENP

SLITRK2

516

Q9H156
EVLLQPNPSARVEEF

SH3GLB2

61

Q9NR46
EIEIQPRVVPNASFF

NAP1L3

426

Q99457
PQTQQVDLDLSRPLF

ORC6

126

Q9Y5N6
QLEEVPSALPRNLEQ

PRELP

161

P51888
REITNQVVPQERQPE

RNF216

186

Q9NWF9
QVVPQERQPEAELGR

RNF216

191

Q9NWF9
EPVLDPQQIQAFDQL

VPS8

1356

Q8N3P4
RVIVQSFPEEPSQVQ

PKHD1

2186

P08F94
NELPVQPQLVFLDEQ

PKHD1

3756

P08F94
VNVRINCIPEQFPTE

SI

71

P14410
LSDNEIQRLPPEVAN

SCRIB

66

Q14160
QIFLPEPEQPSRLQD

ITGA2B

891

P08514
EVPRVLVNLVDFLNP

PLB1

891

Q6P1J6
QEEPQLSPENEARLP

TFCP2L1

31

Q9NZI6
FIPTVREVQCPEANI

AHNAK2

5406

Q8IVF2
LIFNSFLPVNQPEEV

NCAPG2

521

Q86XI2
ATIPRQDEVPQQTVA

TNFRSF10D

56

Q9UBN6
REQPSDPQAEQELIN

VPS50

41

Q96JG6
LEAPVTEPRFLEQLQ

VPS52

186

Q8N1B4
LFRPISAEDEEQQPT

ZPR1

31

O75312
QLPTDPIEEQFPVLN

ZMYND19

131

Q96E35
VFQPNQPLVDSIDLD

WWC2

841

Q6AWC2
PPQQRPRLQEETEAA

TSPYL2

41

Q9H2G4
VFPSNTQPFQRLLEE

WDFY3

736

Q8IZQ1
EIREDENQNIPEQPV

UNC13C

946

Q8NB66
NAPILIQDFETLPRE

VWF

1646

P04275
NLEFVQNQEVLPSEP

SEC16A

461

O15027
IDPRANPTQLNTVEF

TFCP2

161

Q12800
ETVRELLENPVQPIN

TLN1

1371

Q9Y490
QPATENQRVPLIVAA

ARHGAP23

911

Q9P227
EIRDLYVNIQPVQEP

RTCA

221

O00442
ELPQDFLRITPTQQQ

TOLLIP

16

Q9H0E2
FTANPPQRVFELVDQ

TCTN1

131

Q2MV58
PQRVFELVDQINPSI

TCTN1

136

Q2MV58
FINATLPPQERITAQ

TRABD2A

276

Q86V40
NLPENFRRPQTDQAV

SMAP1

101

Q8IYB5
SEFLPPEVNQLLQDV

ZNF518A

776

Q6AHZ1
QALISPRETENNPFE

nan

86

Q6ZUG5
ETLRPSVPEIFNNIQ

PLCH1

1411

Q4KWH8
TFQDDFVPQEIKPRQ

SAXO2

116

Q658L1
RQPPVANLINLTDED

SEC16B

401

Q96JE7
VAVVDQNPSQVRLPA

MYO18B

1011

Q8IUG5
PFKQDVSPIERNEQL

ZNF226

51

Q9NYT6
ARPLDQVLVIDSPNN

ZCCHC18

301

P0CG32
LERAQQLAPSDPQVI

TTC7A

521

Q9ULT0
VRPINAEPVFQAQEI

TASOR2

1671

Q5VWN6
EVNQERSPQPAAVLT

ZBTB38

291

Q8NAP3
VTNAQFPAEIRNLEP

TYW1

511

Q9NV66
DQPPETVIDQVKRFQ

VWA3B

611

Q502W6
QRPNDPETVETILNL

RPTN

46

Q6XPR3
QLFVLQPSRVQPESQ

SLC18A2

266

Q05940
ENIFQTQPLNPILED

EDA2R

206

Q9HAV5
IDENPELFQLRPAQN

PC

481

P11498
LANIPLTPETQRDQE

TFAP4

31

Q01664
PEFQLPVTEPDINNR

SAMD4A

681

Q9UPU9
DVPTLEPQERASVQF

TGM6

656

O95932
PEPQQDEILQRLLFS

TEX46

51

H3BTG2
QFPAEIRNLEPVTQL

TYW1B

451

Q6NUM6
ENPIFVVSREPLNTI

TBK1

376

Q9UHD2
SIQLFPGLREPEEVQ

TGFBR3

431

Q03167
PEELREPQQSFSEAQ

GOLGB1

3126

Q14789
QQQELSRFLNPPSIE

NALCN

1601

Q8IZF0
EVILQIANEPVLPFN

NAALADL2

636

Q58DX5
AQNLQLPPEARIEAS

MYO5A

1386

Q9Y4I1